Effective eclampsia care management remains a global priority in obstetrics to prevent severe maternal morbidity and mortality. A recent ten-year audit from Norway (2013-2022) examined cases from two university hospitals to identify specific learning opportunities. The study population included women diagnosed with eclampsia through documented generalized seizures. Notably, researchers identified critical management gaps in 18 out of the 22 cases reviewed. Furthermore, different clinical management could have potentially prevented eclampsia in eight of these women.

During the study period, there were 22 women identified with an initial diagnosis of eclampsia among over 93,000 deliveries. However, subsequent clinical reviews identified alternative etiologies for seizures in five of those women. This finding highlights the clinical challenge of differential diagnosis in the peripartum period. Moreover, the audit revealed that none of the women received prophylactic magnesium sulfate prior to their first seizure. Consequently, this indicates a significant gap in recognizing the warning signs that necessitate preventative therapy.

Improving Eclampsia Care Management and Clinical Outcomes

The eclampsia working group identified four primary areas where clinical care fell short of established guidelines. First, clinicians underused magnesium sulfate prophylaxis even when patients met the necessary indications. Second, the audit noted inadequate management of hypertension both before and after the eclamptic event. Specifically, blood pressure control was often inconsistent or delayed. Third, there was a notable underuse of cerebral imaging as a diagnostic tool to rule out other neurological conditions. Lastly, many patients lacked a necessary follow-up consultation with an obstetrician after their discharge from the hospital.

Therefore, these findings underscore the need for rigorous adherence to evidence-based protocols. While these results originate from a high-resource setting, the lessons are highly applicable to the Indian context where hypertensive disorders of pregnancy remain a leading cause of maternal death. Specifically, medical teams must prioritize the proactive use of magnesium sulfate and maintain strict blood pressure targets. Furthermore, integrating regular clinical audits into national routine surveillance systems will help identify system-level failures. Ultimately, systematic learning is essential to improve the quality of obstetric care and ensure patient safety.

How can audits improve eclampsia care management?

Clinical audits help identify specific gaps, such as protocol non-adherence or the underuse of critical medications like magnesium sulfate. By reviewing real-world cases, healthcare teams can develop targeted learning systems and training programs to prevent future occurrences of severe maternal morbidity.

What are the common clinical gaps in treating eclampsia?

Research indicates that the underuse of magnesium sulfate prophylaxis and inadequate hypertension control are primary gaps. Additionally, clinicians may overlook the need for cerebral imaging to rule out other causes of seizures, such as stroke or posterior reversible encephalopathy syndrome (PRES), in pregnant patients.

Disclaimer: This content is for informational and educational purposes only and does not constitute medical advice. Always seek the advice of a qualified healthcare provider regarding any medical condition. Refer to the latest local and national guidelines for clinical practice.

References

Mentzoni CT et al. Learning opportunities in eclampsia care: A ten-year audit from Norway, 2013-2022. Acta Obstet Gynecol Scand. 2026 Jun 17. doi: 10.1111/aogs.70280. PMID: 42306880.